ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 62 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $28,000 | -24.3% | 4,773 | -1.0% | 0.00% | – |
| Q3 2019 | $37,000 | +37.0% | 4,823 | +148.5% | 0.00% | – |
| Q2 2019 | $27,000 | +350.0% | 1,941 | +88.3% | 0.00% | – |
| Q1 2019 | $6,000 | +100.0% | 1,031 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -62.5% | 1,031 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | -20.0% | 1,031 | 0.0% | 0.00% | – |
| Q2 2018 | $10,000 | +11.1% | 1,031 | 0.0% | 0.00% | – |
| Q1 2018 | $9,000 | -30.8% | 1,031 | 0.0% | 0.00% | – |
| Q4 2017 | $13,000 | +116.7% | 1,031 | +41.0% | 0.00% | – |
| Q3 2017 | $6,000 | -57.1% | 731 | -9.9% | 0.00% | – |
| Q2 2017 | $14,000 | -44.0% | 811 | -34.1% | 0.00% | -100.0% |
| Q1 2017 | $25,000 | +127.3% | 1,231 | +68.4% | 0.00% | – |
| Q4 2016 | $11,000 | – | 731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |